ReviewCurrent cardiology reports2011
Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.
Review in Current cardiology reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 36 citations in OpenAlex.
- Time-Course Evaluation of the In Vivo Resorption Process of Calcium Phosphates/Poly(lactide-International journal of molecular sciences · 2026Article
- Review of Myocardial Ischemia, Scar, and Viability Estimation with Molecular Magnetic Resonance Imaging.Biomedicines · 2024Review
- [Biomolecules · 2020Article
- Metabolic Reprogramming of Macrophages in Atherosclerosis: Is It All about Cholesterol?Journal of lipid and atherosclerosis · 2020Review
- Advances in coronary molecular imaging: Leveraging the power of image processing.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020Article
- Multiparametric Molecular Imaging of Atherosclerosis: Insights Into Disease Pathology and Risk.Circulation. Cardiovascular imaging · 2020Article
- Metabolism Plays a Key Role during Macrophage Activation.Mediators of inflammation · 2018Review
- Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-/-) Mice.Circulation research · 2016Article
- [¹⁸F-NaF PET-CT: a new method for imaging of ruptured and rupture-endangered atherosclerotic plaques].Der Radiologe · 2014Article
- The role of PET quantification in cardiovascular imaging.Clinical and translational imaging · 2014Article
- PET imaging of inflammation in atherosclerosis.Nature reviews. Cardiology · 2014Review
- New insights into the vulnerable plaque from imaging studies.Current atherosclerosis reports · 2014Review
- Molecular imaging in atherosclerosis: FDG PET.Current atherosclerosis reports · 2012Review
- CT-based handling and analysis of preclinical multimodality imaging data of bone metastases.BoneKEy reports · 2012Article
- 89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging.Bioconjugate chemistry · 2011Article
- Imaging techniques in acute coronary syndromes: a review.ISRN cardiology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Conventional algorithms and noninvasive imaging tests for the identification of stable, hemodynamically significant coronary artery disease offer little insight into the detection of potentially vulnerable and inflamed coronary plaques, those most likely to rupture and cause acute coronary syndromes. Positron emission tomography (PET) with fluorodeoxyglucose (FDG) serves as a potential novel modality for the identification of plaque inflammation, as initial studies in animal and human studies have demonstrated that FDG uptake correlates with macrophage accumulation and inflammation. Therapy with anti-inflammatory agents has also been demonstrated in the arterial vasculature to reduce plaque FDG uptake. Although imaging of coronary inflammation with FDG-PET holds tremendous promise, several hurdles remain to be surmounted prior to widespread clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.